OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)
作者
Sagar Lonial,Paul Gerard Guy Richardson,Rakesh Popat,Edward Allen Stadtmauer,Jeremy Todd Larsen,Albert Oriol,Stefan Tobias Knop,Sundar Jagannath,Gordon Cook,Ashraf Z. Badros,Paula Rodríguez‐Otero,David Samuel DiCapua Siegel,Tuong Vi Nguyen,Antonia Di Micco,Alpesh Amin,Min Chen,Elisabeth Kueenburg,Niels W.C.J. van de Donk